| Dr Laura J Mcmurray, MD | |
|
7315 E Frontage Rd, Suite 101, Shawnee Mission, KS 66204-1654 | |
| (913) 789-3937 | |
| (913) 789-3867 |
| Full Name | Dr Laura J Mcmurray |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 41 Years |
| Location | 7315 E Frontage Rd, Shawnee Mission, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427192806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 04-20574 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.
Toxicology as a science has not evolved to keep pace with the chemical revolution, according to Thomas Hartung writing in the International Journal of Risk Assessment and Management, Hartung highlights ten problems that must be addressed if toxicology is to be made fit for purpose in the 21st Century.
A new study suggests that children with a certain gene defect are more likely to develop a peanut allergy. They studied the effect of changes in the gene filaggrin, which helps the skin block out allergens. They noted what has been seen before – the changes in the gene reduce the effectiveness of the barrier, increasing the risk for eczema and asthma.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Babies born prematurely could be at greater risk of developing kidney diseases later in life according to a landmark study investigating the impacts of preterm birth on kidney development.
› Verified 3 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.
Toxicology as a science has not evolved to keep pace with the chemical revolution, according to Thomas Hartung writing in the International Journal of Risk Assessment and Management, Hartung highlights ten problems that must be addressed if toxicology is to be made fit for purpose in the 21st Century.
A new study suggests that children with a certain gene defect are more likely to develop a peanut allergy. They studied the effect of changes in the gene filaggrin, which helps the skin block out allergens. They noted what has been seen before – the changes in the gene reduce the effectiveness of the barrier, increasing the risk for eczema and asthma.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Babies born prematurely could be at greater risk of developing kidney diseases later in life according to a landmark study investigating the impacts of preterm birth on kidney development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura J Mcmurray, MD 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 676-2126 | Dr Laura J Mcmurray, MD 7315 E Frontage Rd, Suite 101, Shawnee Mission, KS 66204-1654 Ph: (913) 789-3937 |
News Archive
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.
Toxicology as a science has not evolved to keep pace with the chemical revolution, according to Thomas Hartung writing in the International Journal of Risk Assessment and Management, Hartung highlights ten problems that must be addressed if toxicology is to be made fit for purpose in the 21st Century.
A new study suggests that children with a certain gene defect are more likely to develop a peanut allergy. They studied the effect of changes in the gene filaggrin, which helps the skin block out allergens. They noted what has been seen before – the changes in the gene reduce the effectiveness of the barrier, increasing the risk for eczema and asthma.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Babies born prematurely could be at greater risk of developing kidney diseases later in life according to a landmark study investigating the impacts of preterm birth on kidney development.
› Verified 3 days ago
Dr. Kimberly Diane Matthews, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St, Ste 300, Shawnee Mission, KS 66204 Phone: 913-677-3113 Fax: 913-677-4514 | |
Michelle R Dudzinski, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9301 W 74th St, Suite 130, Shawnee Mission, KS 66204 Phone: 913-632-9130 Fax: 913-632-9149 | |
Brenda Shoup, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9301 W 74th St Ste 130, Shawnee Mission, KS 66204 Phone: 913-632-9130 Fax: 913-632-9149 | |
Lowell J Byers, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9301 W 74th St, Suite 130, Shawnee Mission, KS 66204 Phone: 913-632-9130 Fax: 913-632-9149 | |
Kelsi Maxwell Drummond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 300, Shawnee Mission, KS 66204 Phone: 913-677-3113 | |
Dr. Amy Lynn Giedt, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St, Suite 300, Shawnee Mission, KS 66204 Phone: 913-677-3113 Fax: 913-677-4514 | |
Dr. Reagan M Wittek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St, Suite 300, Shawnee Mission, KS 66204 Phone: 913-677-3113 Fax: 913-677-4514 |